Skip to content

Clinical trials

Observational Alzheimer Disease trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Observational Country / region: Sweden Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20072
20101
20131
20152
20161
20181
20202
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting6
Active, not recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Karolinska Institutet5
Skane University Hospital4
AstraZeneca1
Dalarna University1
Indiana University1
Institut National de la Santé Et de la Recherche Médicale, France1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Region Örebro County1
Sahlgrenska University Hospital1
University of Edinburgh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease18
Cognitive Dysfunction10
Dementia7
Dementia, Vascular3
Lewy Body Disease3
Disease2
Parkinson Disease2
Acute Kidney Injury1
Cognition Disorders1
Hip Fractures1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.